Display options
Cite
Gossell-Williams M, Adebayo SA. The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica. Pharm Pract (Granada). 2008;6(4):187-90doi: 10.4321/s1886-36552008000400003.
Gossell-Williams, M., & Adebayo, S. A. (2008). The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica. Pharmacy practice, 6(4), 187-90. https://doi.org/10.4321/s1886-36552008000400003
Gossell-Williams, Maxine, and Adebayo, Sarafadeen A. "The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica." Pharmacy practice vol. 6,4 (2008): 187-90. doi: https://doi.org/10.4321/s1886-36552008000400003
Gossell-Williams M, Adebayo SA. The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica. Pharm Pract (Granada). 2008 Oct;6(4):187-90. doi: 10.4321/s1886-36552008000400003. Epub 2008 Dec 15. PMID: 25157292; PMCID: PMC4141728.
Copy Download .nbib Format: NLM
Share it on

Pharm Pract (Granada). 2008 Oct;6(4):187-90. doi: 10.4321/s1886-36552008000400003. Epub 2008 Dec 15.

The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica.

Pharmacy practice

Maxine Gossell-Williams, Sarafadeen A Adebayo

Affiliations

  1. Department of Basic Medical Sciences, Pharmacology Section, University of the West Indies . Kingston ( Jamaica ).
  2. School of Pharmacy and Health Science. University of Technology , Kingston ( Jamaica ).

PMID: 25157292 PMCID: PMC4141728 DOI: 10.4321/s1886-36552008000400003

Abstract

UNLABELLED: In February 2006, there was a renewed effort to encourage reporting of adverse drug reactions (ADRs) in Jamaica. It involved renaming the process the "PharmWatch" programme and revising the reporting form.

OBJECTIVES: The aims of this study were to assess the attitudes of community pharmacists to ADR reporting and to assess their utilization of the PharmWatch programme.

METHODS: The survey was conducted in January 2007, involving 102 community pharmacists islandwide. A questionnaire was designed to assess their attitudes towards ADR reporting, their awareness of the PharmWatch programme and also to collate number of ADRs through recall. Pharmacists were then followed prospectively to collect ADRs occurring over the next three months using the PharmWatch form.

RESULTS: Although most of the pharmacists involved in the survey had more than five years of experience, the majority (67%) were not aware of the PharmWatch programme; however, 86% of the responding pharmacists indicated that they accepted that ADR reporting was a professional responsibility. They identified "reaction already known", "more information needed about reporting ADRs" and "lack of time" as key factors that would cause non-reporting. One hundred and twenty eight retrospective ADRs were collected; none were reported to the Ministry of Health directly, while two were reported to the respective drug companies. A three month prospective follow-up with pharmacists yielded 45 reports. The most common ADR reports among both the retrospective and prospective data were associated with anti-infectives.

CONCLUSIONS: The results suggest that awareness of the PharmWatch programme is not adequate to facilitate active participation in ADR reporting. More proactive interventions, such as continuous training and encouragement in the use of ADR reporting should be considered.

Keywords: Adverse Drug Reaction Reporting Systems; Jamaica; Pharmacists

References

  1. JAMA. 2002 May 1;287(17):2215-20 - PubMed
  2. Br J Clin Pharmacol. 2005 Aug;60(2):221-3 - PubMed
  3. Drug Saf. 2000 Aug;23(2):165-72 - PubMed
  4. Neurogastroenterol Motil. 2008 Mar;20(3):177-84 - PubMed
  5. Br J Clin Pharmacol. 2001 Jan;51(1):81-6 - PubMed
  6. Pharmacol Rev. 2001 Sep;53(3):357-79 - PubMed
  7. Basic Clin Pharmacol Toxicol. 2008 Mar;102(3):275-80 - PubMed
  8. Am J Health Syst Pharm. 2007 Apr 15;64(8):842-9 - PubMed
  9. Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):457-64 - PubMed
  10. Drug Saf. 2008;31(4):335-44 - PubMed
  11. Arch Intern Med. 2005 Jun 27;165(12):1363-9 - PubMed
  12. West Indian Med J. 2007 Oct;56(5):458-63 - PubMed
  13. Drug Saf. 2007;30(11):1073-82 - PubMed
  14. Ann Pharmacother. 2007 May;41(5):742-8 - PubMed
  15. Ther Clin Risk Manag. 2005 Sep;1(3):181-8 - PubMed
  16. Lancet. 2000 Oct 7;356(9237):1255-9 - PubMed
  17. Arch Dermatol. 2001 Jun;137(6):765-70 - PubMed
  18. Subcell Biochem. 2007;42:3-27 - PubMed

Publication Types